603939 益丰药房
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入17,285,9000.39%24,062,15522,588,22719,886,39615,326,305
减:营业总成本15,631,502-0.51%21,973,89320,616,59718,008,27514,045,641
    其中:营业成本10,301,5390.37%14,408,31113,957,59912,025,5649,142,818
               财务费用113,022-7.68%173,90386,185104,812114,870
               资产减值损失(71,650)19.91%(102,396)(72,634)(56,019)(40,746)
公允价值变动收益------------
投资收益99,77029.90%108,12942,3726,86934,368
    其中:对联营企业和合营企业的投资收益----(1)317(11)--
营业利润1,786,80112.69%2,203,8242,054,7851,885,5331,338,867
利润总额1,769,95612.02%2,182,4472,037,5941,877,4871,337,906
减:所得税费用448,78917.62%529,665456,663454,061347,157
净利润1,321,16710.24%1,652,7821,580,9311,423,426990,749
减:非控股权益96,6119.89%124,206168,946161,585102,864
股东净利润1,224,55610.27%1,528,5771,411,9851,261,841887,884

市场价值指针
每股收益 (元) *1.0109.78%1.2601.1701.2601.250
每股派息 (元) *0.30020.00%0.6500.5000.4000.300
每股净资产 (元) *9.0379.22%8.6649.70211.85510.409
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容